Discrepancies in breast cancer guideline recommendations despite similar Cochrane systematic review conclusions

Zhigang Zhang, Jie Cheng, Jialu Hou, Mingming Niu, Ya Gao, Jianguo Xu, Qingyong Zheng, Kexin Ji, Min Zhang, Tian Hao, Ning Li, Xinyi Han, Xiujuan Ma, Jiajia Kong, Rui Wang, Ye Zhao, Jinhui Tian, Xiao HuJournal of Evidence-Based Medicine 2024 · DOI

Abstract

The average number of citations for CSR on breast cancer in the guidelines was 5.91. There were also situations in which the guideline recommendations were inconsistent with the conclusions of the included systematic reviews, and recommendations on the same topic across different guidelines were inconsistent.
BibTeX
@article{zhang2024discrepancies,
  author = {Zhigang Zhang and Jie Cheng and Jialu Hou and Mingming Niu and Ya Gao and Jianguo Xu and Qingyong Zheng and Kexin Ji and Min Zhang and Tian Hao and Ning Li and Xinyi Han and Xiujuan Ma and Jiajia Kong and Rui Wang and Ye Zhao and Jinhui Tian and Xiao Hu},
  title = {{Discrepancies in breast cancer guideline recommendations despite similar Cochrane systematic review conclusions}},
  journal = {Journal of Evidence-Based Medicine},
  year = {2024},
  doi = {10.1111/jebm.12581},
}

Loading related content...

Figure